Literature DB >> 15780591

Recent advances in the protein kinase B signaling pathway.

James R Woodgett1.   

Abstract

The phosphoinositide 3' kinase signaling pathway is activated in response to a plethora of growth factors and cytokines, and initiates a cascade of signaling events primarily via the induction of specific protein-serine/threonine kinases. Interest in the pathway has been driven by its frequent aberrant activation in disease and its impact on cell fate decisions owing to roles in survival signaling and metabolic control. There have been recent advances in our understanding of the primary components of this pathway, namely phosphoinositide-dependent kinase-1, protein kinase B and glycogen synthase kinase-3, including insights into their mechanisms of regulation, substrate proteins and cellular functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780591     DOI: 10.1016/j.ceb.2005.02.010

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  124 in total

Review 1.  Akt isoform-specific signaling in breast cancer: uncovering an anti-migratory role for palladin.

Authors:  Y Rebecca Chin; Alex Toker
Journal:  Cell Adh Migr       Date:  2011-05-01       Impact factor: 3.405

2.  Oxidation of Akt2 kinase promotes cell migration and regulates G1-S transition in the cell cycle.

Authors:  Revati Wani; N Sharmila Bharathi; Jeffrey Field; Allen W Tsang; Cristina M Furdui
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

3.  Small molecule-induced cytosolic activation of protein kinase Akt rescues ischemia-elicited neuronal death.

Authors:  Hakryul Jo; Subhanjan Mondal; Dewar Tan; Eiichiro Nagata; Shunya Takizawa; Alok K Sharma; Qingming Hou; Kumaran Shanmugasundaram; Amit Prasad; Joe K Tung; Alexander O Tejeda; Hengye Man; Alan C Rigby; Hongbo R Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

Review 4.  The potential role of mTOR inhibitors in the treatment of endocrine tumors.

Authors:  S Grozinsky-Glasberg; I Shimon
Journal:  J Endocrinol Invest       Date:  2010-05-05       Impact factor: 4.256

5.  Hydroxysafflor yellow A protects against cerebral ischemia-reperfusion injury by anti-apoptotic effect through PI3K/Akt/GSK3β pathway in rat.

Authors:  Lin Chen; Yanxiao Xiang; Lingjun Kong; Xiumei Zhang; Baozhu Sun; Xinbing Wei; Huiqing Liu
Journal:  Neurochem Res       Date:  2013-08-29       Impact factor: 3.996

6.  Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development.

Authors:  Aditi Mukherjee; Peter Rotwein
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

7.  Delineating the signals by which repetitive deformation stimulates intestinal epithelial migration across fibronectin.

Authors:  Christopher P Gayer; Lakshmi S Chaturvedi; Shouye Wang; Brittany Alston; Thomas L Flanigan; Marc D Basson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-29       Impact factor: 4.052

8.  PHLPP1 mediates melanoma metastasis suppression through repressing AKT2 activation.

Authors:  Yanlin Yu; Meng Dai; Andrew Lu; Ellen Yu; Glenn Merlino
Journal:  Oncogene       Date:  2018-02-02       Impact factor: 9.867

9.  Distinct actions of Akt1 and Akt2 in skeletal muscle differentiation.

Authors:  Peter Rotwein; Elizabeth M Wilson
Journal:  J Cell Physiol       Date:  2009-05       Impact factor: 6.384

10.  Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses.

Authors:  Venugopalan D Nair; C Warren Olanow
Journal:  J Biol Chem       Date:  2008-04-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.